John Pullman - Concepedia

Author

John Pullman

Also Known As

Ashwin Dhanrajji Porwal, Hien Nguyen, J Pullman, J. PULLMAN, J. Pullman, J. Scott Overcash, John Pullman, John R. Pullman, Richard Beasley, Stephanie Whitten

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

State Street (United States)Sanford Research University of Calgary Melinta Therapeutics (United States)Seres Therapeutics (United States)

About

John Pullman is an author at State Street (United States) specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	204
2	Health Sciences	3	3	85
3	Microbiology	2	2	28
4	Immunology	1	1	12
5	Pharmacology	1	1	12

John Pullman

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes Thomas Blevins, John Pullman, Jaret Malloy, The Journal of Clinical Endocrinology & Metabolism	2011	442
Efficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise Ralph A. DeFronzo, Richard M. Bergenstal, William T. Cefalu, Diabetes Care	2005	135
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study Richard Vickers, Glenn Tillotson, Richard Nathan, The Lancet Infectious Diseases	2017	115
Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study John Pullman, Jānis Gardovskis, Brett Farley, Journal of Antimicrobial Chemotherapy	2017	100
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis Andrej Spec, John Pullman, George R. Thompson, Journal of Antimicrobial Chemotherapy	2019	83
Age-Dependent<i>Neisseria meningitidis</i>Serogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine Susan E. Maslanka, Jordan W. Tappero, Brian D. Plikaytis, Infection and Immunity	1998	76
In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections S. M. Hamilton, Amy E. Bryant, Karen C. Carroll, Clinical Infectious Diseases	2007	75
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin Jeff Kingsley, Purvi Mehra, Laura Lawrence, Journal of Antimicrobial Chemotherapy	2015	75
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study Martín E. Stryjewski, Arnold Lentnek, William O’Riordan, BMC Infectious Diseases	2014	68
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials Dale N. Gerding, Oliver A. Cornely, Simon Grill, The Lancet Infectious Diseases AntibioticsClostridium Difficile InfectionAntibiotic AdjuvantRandomised Phase 3Pharmacotherapy	2019	61

Page 1